How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,371 results for

ADHD Resources

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population

Provider, Investigator, Outcomes Assessor) Primary Purpose: Treatment Official Title: Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population Study Start Date : December 2015 Estimated Primary Completion Date : December 2018 Estimated Study Completion Date : December 2019 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Melatonin (...) : January 7, 2015 Last Update Posted: October 25, 2017 Last Verified: October 2017 Keywords provided by Sunita Vohra, University of Alberta: Melatonin Additional relevant MeSH terms: Layout table for MeSH terms Disease Attention Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms Melatonin Central Nervous

2014 Clinical Trials

102. Supplementation of Polyunsaturated Fatty Acids in Children With Attention Deficit/Hyperactivity Disorder (ADHD)

acids, PUFA Additional relevant MeSH terms: Layout table for MeSH terms Attention Deficit Disorder with Hyperactivity Hyperkinesis Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms (...) Supplementation of Polyunsaturated Fatty Acids in Children With Attention Deficit/Hyperactivity Disorder (ADHD) Supplementation of Polyunsaturated Fatty Acids in Children With Attention Deficit/Hyperactivity Disorder (ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2014 Clinical Trials

103. Behavioral Intervention for Children With Attention Deficit Hyperactivity Disorder(ADHD)

Behavioral Intervention for Children With Attention Deficit Hyperactivity Disorder(ADHD) Behavioral Intervention for Children With Attention Deficit Hyperactivity Disorder(ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies (...) before adding more. Behavioral Intervention for Children With Attention Deficit Hyperactivity Disorder(ADHD) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02327585 Recruitment Status : Unknown Verified December 2014 by Min Chen, Peking University. Recruitment status was: Recruiting First Posted

2014 Clinical Trials

104. Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Model: Crossover Assignment Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Primary Purpose: Other Official Title: A Randomized, Sequential Parallel, Double-Blind, Placebo- Controlled Medical Food Study for the Safety and Efficacy of Vayarin® in Adults With Attention Deficit Hyperactivity Disorder (ADHD) Study Start Date : October 2014 Actual Primary Completion Date : May 2017 Actual Study Completion Date : June 2017 Resource links provided by the National Library (...) Verified: January 2017 Additional relevant MeSH terms: Layout table for MeSH terms Disease Attention Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms

2014 Clinical Trials

105. Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)

: December 2015 Keywords provided by Vernalis (R&D) Ltd: ADHD Attention Deficit/ Hyperactivity Disorder Additional relevant MeSH terms: Layout table for MeSH terms Attention Deficit Disorder with Hyperactivity Hyperkinesis Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms (...) Official Title: A Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Repeat Oral Doses of V81444 in Volunteers With Attention Deficit / Hyperactivity Disorder (ADHD) Study Start Date : July 2013 Actual Primary Completion Date : March 2014 Actual Study Completion Date : April 2014 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Placebo:V81444

2014 Clinical Trials

106. Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)

areas of functioning. Parents will also be asked to obtain information from the child's teacher regarding the child's functioning at 6 month intervals during the school year. Condition or disease Intervention/treatment Phase Attention Deficit Hyperactivity Disorder (ADHD) Behavioral: Academic and Organization skills Behavioral: Parent Training Behavioral: Social Skills Training Drug: Long-acting stimulant Not Applicable Study Design Go to Layout table for study information Study Type (...) Additional relevant MeSH terms: Layout table for MeSH terms Disease Attention Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms Central Nervous System Stimulants Methylphenidate Lisdexamfetamine Dimesylate Adderall Dextroamphetamine Atomoxetine Hydrochloride Physiological Effects of Drugs Dopamine Uptake

2014 Clinical Trials

107. The global burden of conduct disorder and attention-deficit/hyperactivity disorder in 2010. Full Text available with Trip Pro

The global burden of conduct disorder and attention-deficit/hyperactivity disorder in 2010. The Global Burden of Disease Study 2010 (GBD 2010) is the first to include conduct disorder (CD) and attention-deficit/hyperactivity disorder (ADHD) for burden quantification.A previous systematic review pooled the available epidemiological data for CD and ADHD, and predicted prevalence by country, region, age and sex for each disorder. Prevalence was then multiplied by a disability weight to calculate (...) contributor and among the 15 leading causes in children aged 5-19 years. Between 1990 and 2010, global DALYs attributable to CD and ADHD remained stable after accounting for population growth and ageing.The global burden of CD and ADHD is significant, particularly in male children. Appropriate allocation of resources to address the high morbidity associated with CD and ADHD is necessary to reduce global burden. However, burden estimation was limited by data lacking for all four epidemiological parameters

2014 Journal of Child Psychology and Psychiatry

108. Attention Deficit-Hyperactivity Disorder

Attention Deficit-Hyperactivity Disorder Rotation Prep | NEJM Resident 360 Social Login Email Login Log in via Email Create Your Account We will not share your email with anyone. Password must be at least 8 characters. Show or Hide the password you are typing. Request to Join has invited you to join this group Your browser does not support video tags Welcome! NEJM Resident 360 helps you prepare for your next rotation quickly and efficiently, provides support for coping with the pressures (...) of resident life, and equips you to take the next major step in your career. Rotation Prep supports your learning with an overview of the basics, and expertly chosen resources that provide the foundational information you need. Explore the educational features in Learning Lab, ways to connect with peers in Resident Lounge, and find career tips and guidance in Career. Exploring , , , and is FREE. Access to Rotation Prep is FREE to you through your institution's subscription, or you may connect

2014 Now@NEJM

109. A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain Full Text available with Trip Pro

(both immediate and extended release) or no treatment, in Spanish children with attention deficit hyperactivity disorder (ADHD). Interventions Methylphenidate, a mild stimulant and the most common treatment for children with ADHD, was compared with atomoxetine, a new non-stimulant alternative, in Spain. The study also compared no medication to capture those patients who could not receive stimulant medication due to a previous adverse experience or co-morbidities. Three populations were evaluated (...) A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain Hong J, Dilla T, Arellano

2009 NHS Economic Evaluation Database.

110. A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)

with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms Amphetamine Central Nervous System Stimulants Physiological Effects of Drugs Sympathomimetics Autonomic Agents Peripheral Nervous System Agents Dopamine Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic Agents Adrenergic Uptake Inhibitors (...) A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD) A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD) - Full Text View

2013 Clinical Trials

111. Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment

-STILL First Posted: October 14, 2013 Last Update Posted: October 14, 2013 Last Verified: September 2013 Keywords provided by Hadassah Medical Organization: EEG Attention Deficit / Hyperactivity Disorder (ADHD) Ritalin machine learning Additional relevant MeSH terms: Layout table for MeSH terms Disease Attention Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic (...) Signature of Brain Activity of Electroencephalogram Records in Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment Study Start Date : October 2013 Estimated Primary Completion Date : December 2015 Estimated Study Completion Date : December 2015 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Ritalin Ritalin treatment at different doses Drug: Ritalin Patients with ADHD

2013 Clinical Trials

112. NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)

terms Disease Attention Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms (...) NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies

2013 Clinical Trials

113. An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD)

table for additonal information Responsible Party: Tsuyoshi Sasaki, Assistant Professor, Chiba University ClinicalTrials.gov Identifier: Other Study ID Numbers: G24061 First Posted: April 18, 2013 Last Update Posted: February 21, 2014 Last Verified: February 2014 Additional relevant MeSH terms: Layout table for MeSH terms Attention Deficit Disorder with Hyperactivity Hyperkinesis Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic (...) An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD) An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please

2013 Clinical Trials

114. Risk Perception in Adults With Attention Deficit and Hyperactivity Disorder (ADHD)

for their risky behavior. In contrast, it is hypothesized that people with ADHD do not show increased risk attitude, namely, they are not risk seeking. Condition or disease ADHD Study Design Go to Layout table for study information Study Type : Observational Actual Enrollment : 60 participants Observational Model: Case Control Time Perspective: Cross-Sectional Official Title: Risk Perception in Adults With Attention Deficit and Hyperactivity Disorder (ADHD) Study Start Date : November 2014 Actual Primary (...) : riskperception.ctil First Posted: November 26, 2013 Last Update Posted: November 18, 2015 Last Verified: July 2015 Additional relevant MeSH terms: Layout table for MeSH terms Attention Deficit Disorder with Hyperactivity Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders

2013 Clinical Trials

115. A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants

Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: An Open, Self-Controlled, Prospective Study of Concerta on Cognitive Functions, Efficacy and Tolerance in the Pediatric Patients With Attention Deficit Hyperactivity Disorder (ADHD) Study Start Date : December 2009 Actual Primary Completion Date : November 2010 Actual Study Completion Date : November 2010 Resource links provided by the National Library of Medicine related topics: available for: Arms (...) : September 2014 Keywords provided by Xian-Janssen Pharmaceutical Ltd.: Attention Deficit Hyperactivity Disorder Methylphenidate Hydrochloride CONCERTA Additional relevant MeSH terms: Layout table for MeSH terms Disease Attention Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms Methylphenidate Central Nervous

2013 Clinical Trials

116. NIRS Neurofeedback as a Treatment for Attention Deficit Hyperactivity Disorder

Spectroscopy ADHD Additional relevant MeSH terms: Layout table for MeSH terms Disease Attention Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms (...) Type : Interventional (Clinical Trial) Estimated Enrollment : 10 participants Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: Clinical Trial Using NIRS Neurofeedback on Children With Attention Deficit Hyperactivity Disorder (ADHD) Study Start Date : July 2014 Estimated Primary Completion Date : July 2015 Estimated Study Completion Date : July 2015 Resource links provided by the National Library of Medicine related topics: Arms

2014 Clinical Trials

117. Plasma Orexin A and mRNA Expression Levels of Pre-pro-orexin Gene in Attention-Deficit Hyperactivity Disorder

Orexin A and mRNA Expression Levels of Pre-pro-orexin Gene in Attention-Deficit Hyperactivity Disorder Study Start Date : January 2011 Actual Primary Completion Date : December 2011 Resource links provided by the National Library of Medicine related topics: Groups and Cohorts Go to Outcome Measures Go to Primary Outcome Measures : SNAP-IV [ Time Frame: baseline ] self-administered questionnaires to measures ADHD symptoms Biospecimen Retention: Samples With DNA mRNA,pre-pro-orexin gene Eligibility (...) Keywords provided by National Taiwan University Hospital: Attention-deficit/hyperactivity disorder orexin A mRNA Additional relevant MeSH terms: Layout table for MeSH terms Disease Attention Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms

2014 Clinical Trials

118. Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial

. Condition or disease Intervention/treatment Phase Attention Deficit Disorder With Hyperactivity Disease Hyperkinesis Attention Deficit and Disruptive Behavior Disorders Drug: Tipepidine Hibenzate Drug: Placebo Phase 1 Phase 2 Detailed Description: Tipepidine (3-[di-2-thienylmethylene]-1-methylpiperidine) has been used solely as a nonnarcotic antitussive in Japan since 1959. The safety of tipepidine in children and adults has already been established. It is reported that tipepidine inhibits G-protein (...) potassium (GIRK)-channel currents. The inhibition of GIRK channels by tipepidine is expected to modulate the level of monoamines in the brain. We put forward the hypothesis that tipepidine can improve attention deficit/hyperactivity disorder (ADHD) symptoms by modulating monoaminergic neurotransmission through the inhibition of GIRK channels. The purpose of this double-blind, placebo-controlled trial is to confirm whether treatment with tipepidine can improve symptoms in pediatric patients with ADHD

2014 Clinical Trials

119. Psychostimulants Effects on Brain Functional Connectivity in Youth With Attention Deficit Hyperactivity Disorder

: Randomized Intervention Model: Crossover Assignment Masking: Double (Participant, Investigator) Official Title: An Electroencephalography Study of the Effects of Psychostimulants on Dynamic Patterns of Cognitive Task-based Functional Connectivity in Youths With Attention Deficit Hyperactivity Disorder Study Start Date : December 2014 Estimated Primary Completion Date : December 2016 Estimated Study Completion Date : December 2017 Resource links provided by the National Library of Medicine related topics (...) Gothelf, Prof. , . 972-3-5303810 More Information Go to Layout table for additonal information Responsible Party: Sheba Medical Center ClinicalTrials.gov Identifier: Other Study ID Numbers: SHEBA-14-1351-IH-CTIL First Posted: December 17, 2014 Last Update Posted: December 17, 2014 Last Verified: December 2014 Keywords provided by Sheba Medical Center: adhd global network eeg Additional relevant MeSH terms: Layout table for MeSH terms Attention Deficit Disorder with Hyperactivity Attention Deficit

2014 Clinical Trials

120. Efficacy of Combined Treatment With CoQ10 and Methylphenidate in Children With Attention Deficit Hyperactivity Disorder

Medical Center ClinicalTrials.gov Identifier: Other Study ID Numbers: 7636 First Posted: December 12, 2014 Last Update Posted: December 12, 2014 Last Verified: October 2014 Additional relevant MeSH terms: Layout table for MeSH terms Disease Attention Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms (...) With Attention Deficit Hyperactivity Disorder Study Start Date : January 2015 Estimated Primary Completion Date : November 2015 Estimated Study Completion Date : November 2016 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Coenzyme Q10 30 children aged 6-12 will consume daily a snack containing 60 mg of CoQ10 for 8 weeks. Dietary Supplement: Coenzyme Q10 A snack containing 60 mg of Coenzyme Q10

2014 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>